Journal
NUCLEIC ACIDS RESEARCH
Volume 49, Issue D1, Pages D1268-D1275Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkaa1104
Keywords
-
Categories
Funding
- Shenzhen City and Longgang District
- Shenzhen Ganghong Group Co., Ltd.
Ask authors/readers for more resources
This study updated MethHC 2.0 by incorporating additional DNA methylomes and transcriptomes from various public repositories, providing enhanced data annotation functionality and a user-friendly web interface.
DNA methylation is an important epigenetic regulator in gene expression and has several roles in cancer and disease progression. MethHC version 2.0 (MethHC 2.0) is an integrated and web-based resource focusing on the aberrant methylomes of human diseases, specifically cancer. This paper presents an updated implementation of MethHC 2.0 by incorporating additional DNA methylomes and transcriptomes from several public repositories, including 33 human cancers, over 50 118 microarray and RNA sequencing data from TCGA and GEO, and accumulating up to 3586 manually curated data from >7000 collected published literature with experimental evidence. MethHC 2.0 has also been equipped with enhanced data annotation functionality and a user-friendly web interface for data presentation, search, and visualization. Provided features include clinical-pathological data, mutation and copy number variation, multiplicity of information (gene regions, enhancer regions, and CGI regions), and circulating tumor DNA methylation profiles, available for research such as biomarker panel design, cancer comparison, diagnosis, prognosis, therapy study and identifying potential epigenetic biomarkers. MethHC 2.0 is now available at http://awi.cuhk.edu.cn/similar to MethHC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available